Skip to main content
Equibles

Advisors Asset Management, Inc.

Position in ASND — Ascendis Pharma A/S

CIK 1297376 Monument, CO
Back to ASND Full portfolio

Position in ASND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,439,421
-$351,085 QoQ
Shares Held
9,146
-25.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#149
of 309 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Advisors Asset Management, Inc. holds $39,929,265 across 31 Biotechnology names. ASND ranks #5 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 25,909 $12,869,777
2 LGND
Ligand Pharmaceuticals Inc
 17,228 $5,445,598
3 INCY
Incyte Corp
 24,359 $2,761,336
4 ARQT
Arcutis Biotherapeutics, Inc.
 95,934 $2,515,389
5 ASND
Ascendis Pharma A/S
This page 		9,146 $2,439,421
6 RYTM
Rhythm Pharmaceuticals, Inc.
 21,896 $2,431,112
7 REGN
Regeneron Pharmaceuticals, Inc.
 2,379 $1,483,401
8 PTCT
Ptc Therapeutics, Inc.
 15,280 $1,246,389

All Filings in ASND

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,439,421 9,146
2026-03-31 $2,790,506 12,200
2025-12-31 $2,642,896 12,394
2025-09-30 $2,109,175 10,609
2025-06-30 $1,807,467 10,472
2025-03-31 $1,432,353 9,190
2024-12-31 $1,134,538 8,241
2024-09-30 $708,028 4,742
2024-06-30 $524,790 3,848
2023-09-30 $516,799 5,519
2023-06-30 $501,317 5,617
2023-03-31 $631,204 5,887
2022-12-31 $750,000 6,141
2022-09-30 $1,633,160 15,816
2022-06-30 $1,556,987 16,749
2022-03-31 $1,968,244 16,771
2021-12-31 $2,186,247 16,251
2021-09-30 $2,360,247 14,808
2021-06-30 $1,975,881 15,020
2021-03-31 $1,775,966 13,780
2020-12-31 $1,419,798 8,513
2020-09-30 $709,409 4,597
2020-06-30 $597,072 4,037
2020-03-31 $151,347 1,344